IL-32α suppresses colorectal cancer development via TNFR1-mediated death signaling.
about
Tumor necrosis factor receptor 2/AKT and ERK signaling pathways contribute to the switch from fibroblasts to CAFs by progranulin in microenvironment of colorectal cancer.Revealing potential molecular targets bridging colitis and colorectal cancer based on multidimensional integration strategy.Myelin oligodendrocyte glycoprotein (MOG35-55)-induced experimental autoimmune encephalomyelitis is ameliorated in interleukin-32 alpha transgenic mice.IL-32θ gene expression in acute myeloid leukemia suppresses TNF-α production.IL-32θ inhibits stemness and epithelial-mesenchymal transition of cancer stem cells via the STAT3 pathway in colon cancerDe novo AML exhibits greater microenvironment dysregulation compared to AML with myelodysplasia-related changes.Major apoptotic mechanisms and genes involved in apoptosis.Interleukin-32α Inhibits Endothelial Inflammation, Vascular Smooth Muscle Cell Activation, and Atherosclerosis by Upregulating Timp3 and Reck through suppressing microRNA-205 Biogenesis.Von Hippel-Lindau regulates interleukin-32β stability in ovarian cancer cells.Anticancer Applications of Nanostructured Silica-Based Materials Functionalized with Titanocene Derivatives: Induction of Cell Death Mechanism through TNFR1 Modulation.IL-32θ: a recently identified anti-inflammatory variant of IL-32 and its preventive role in various disorders and tumor suppressor activity.Role of interleukin-32 in cancer biology.Inflammatory-Related P62 Triggers Malignant Transformation of Mesenchymal Stem Cells through the Cascade of CUDR-CTCF-IGFII-RAS Signaling.
P2860
Q33688650-1F688806-EC6D-4482-8817-EC38B4F2063CQ36545820-0D3AE7C6-F906-4BEC-AFE2-A5BF311E96D9Q36562052-67AD7D90-725A-4734-A570-2E3F75AD7EAAQ36562157-B56AB260-DDD6-4881-887B-65F99A21459DQ36916472-3F130C7B-AFA2-4FC4-9C14-A366761E2317Q37584726-900D1D5B-A692-4249-AC89-A7EAA3236350Q38802454-0A8CD190-2A0B-4214-B866-2778E27C375BQ40980359-7BA14BE2-9239-467D-9A1A-EB0DB2479EF1Q42378385-60780D6E-CB63-4F1F-857F-E3D584F72201Q48133932-AF3A4514-FA16-4246-B6FF-D6F0FA752606Q49320015-6B4A4964-C117-4824-9327-04283959530EQ55264916-EC0C1F82-F614-455A-8CCB-69C299808A8BQ55361622-A4E44557-480B-4D62-A464-D026AFC58FC1
P2860
IL-32α suppresses colorectal cancer development via TNFR1-mediated death signaling.
description
2015 nî lūn-bûn
@nan
2015年の論文
@ja
2015年論文
@yue
2015年論文
@zh-hant
2015年論文
@zh-hk
2015年論文
@zh-mo
2015年論文
@zh-tw
2015年论文
@wuu
2015年论文
@zh
2015年论文
@zh-cn
name
IL-32α suppresses colorectal cancer development via TNFR1-mediated death signaling.
@ast
IL-32α suppresses colorectal cancer development via TNFR1-mediated death signaling.
@en
type
label
IL-32α suppresses colorectal cancer development via TNFR1-mediated death signaling.
@ast
IL-32α suppresses colorectal cancer development via TNFR1-mediated death signaling.
@en
prefLabel
IL-32α suppresses colorectal cancer development via TNFR1-mediated death signaling.
@ast
IL-32α suppresses colorectal cancer development via TNFR1-mediated death signaling.
@en
P2093
P2860
P356
P1433
P1476
IL-32α suppresses colorectal cancer development via TNFR1-mediated death signaling.
@en
P2093
Do Young Yoon
Eun-Cheol Kim
Hyung-Mun Yun
Jin Tae Hong
Kyung-Ran Park
Sang Bae Han
P2860
P304
P356
10.18632/ONCOTARGET.3197
P407
P577
2015-04-01T00:00:00Z